Literature DB >> 16914715

Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.

Jerry L Spivak, Alison R Moliterno, Richard T Silver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16914715     DOI： 10.1056/NEJMc061631

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Budd-Chiari Syndrome in a Patient with JAK-2 V617F and Factor V G1691A Mutations.

Authors:  J S Velarde-Félix; J Sanchez-Zazueta; F P Gonzalez-Ibarra; J A González-Valdez; B Salcido-Gómez; E Gallardo-Angulo; J Murillo-Llanes
Journal:  West Indian Med J       Date:  2014-06-10       Impact factor: 0.171

2.  The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.

Authors:  Ipek Yonal; Binnur Pinarbası; Fehmi Hindilerden; Veysel Sabri Hancer; Meliha Nalcaci; Sabahattin Kaymakoglu; Reyhan Diz-Kucukkaya
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

3.  Abdominal venous thrombosis presenting in myeloproliferative neoplasm with JAK2 V617F mutation: a case report.

Authors:  Naveen Pemmaraju; James Peter Hamilton; Andrew M Cameron; Stephen Sisson; Alison R Moliterno
Journal:  J Med Case Rep       Date:  2012-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.